Skip to content
Tenfell
Awarded contract
Published 24 Sep 2018

Contract Award for the provision of H1V-1 LAg-Avidity ElA to Determine Recency of Infection

Public Health England · United Kingdom

Key facts

Contract value
£38,100
Awarded
20 Sep 2018
Contract starts
20 Sep 2018
Contract ends
21 Sep 2019
Procedure
Negotiated procedure without prior publication (above threshold)
Buyer type
Central government

Awarded to

SupplierValue
Sedia Biosciences Corporation£38,100

Description

Public Health England (PHE) has awarded a contract for the provision of H1V-1 LAg-Avidity ElA kits to Sedia Biosciences Corporation, which is used to monitor recent HIV infection in people in newly diagnosed with HIV as part of national Surveillances.

To ensure comparability of data, the same assay is required over time to minimise any variation between assays performance. Sedia LAg assays are used to monitor recent infections in the UK. Sedia Biosciences Corporation is the only manufacturer of the Sedia LAg assay. Alternative LAg assays have been shown to have different performance characteristics following evaluation. Sufficient data have been generated on the Sedia LAg assay to confirm that it meets our performance characteristics and that these data are in line with that published by the manufacturer including an MDRI of approx. 130 days at a normalised ODn of 1.5.

Additional information: VEAT notice details:

OJEU Document Number 2018/S 167-380498

Notice Reference 2018-041795

Categories (CPV)

Similar open tenders

About Public Health England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.